Nicotinic Receptor, alpha 5 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Nicotinic Receptor, alpha 5 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Nicotinic Receptor, alpha 5 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | serum |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | ELISA (EL/EIA), Western Blot (WB), Immunocytochemistry (ICC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recognizes Nicotinic alpha5 receptor (aa460-468) and the reactivity of Nicotinic alpha5 receptor is ~95%. Does not react to Nicotinic alpha3 receptor, Nicotinic alpha4 receptor, Nicotinic alpha7 receptor, Nicotinic beta2 receptor, Nicotinic beta3 receptor and Nicotinic beta4 receptor. Specific for the COOH terminal of nicotinic alpha5 receptor. Acetylcholine receptors (AChRs) mediate synaptic transmission at the neuromuscular junction. The channel-linked AChR that mediates rapid, excitatory actions of acetylcholine is called nicotinic AChR (nAChR) because it can be activated by nicotine. The non-channel linked AChR that medicates the slow actions of acetylcholine, which can be either inhibitory or excitatory, is called muscarinic AChR (mACh |
| Immunogen | Immunogen: Synthetic peptide composed of aa460-468 from the carboxyl terminal of human nicotinic alpha5 receptor. |
| Other Names | [-Nicotinic Receptor, alpha 5], [CHRNA7; CHRNA7; NACHRA7; CHRNA7-2; NACHRA7] |
| Gene, Accession # | Gene ID: 1139, NCBI: NP_000737.1, UniProt: P36544 |
| Catalog # | MBS628607 |
| Price | $440 |
| Order / More Info | Nicotinic Receptor, alpha 5 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies